| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/19/2002 | WO2002072880A2 Method for detecting cytosine methylation patterns having high sensitivity |
| 09/19/2002 | WO2002072878A2 Method for forgery-proof marking; forgery-proof marking and kit |
| 09/19/2002 | WO2002072874A1 METHOD OF SCREENING HNF4α AGONIST |
| 09/19/2002 | WO2002072873A1 Method of preparing supported lipid film membranes and use thereof |
| 09/19/2002 | WO2002072872A2 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby |
| 09/19/2002 | WO2002072871A2 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 09/19/2002 | WO2002072868A2 Methods and tools for nucleic acid sequence analysis selection and generation |
| 09/19/2002 | WO2002072866A2 Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma |
| 09/19/2002 | WO2002072863A2 Methods for large scale protein matching |
| 09/19/2002 | WO2002072833A1 Cloning of the cdna that codes for cup s 1, the major allergen of cupressus sempervirens |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072829A1 Novel g protein-coupled receptor protein and dna thereof |
| 09/19/2002 | WO2002072825A2 Human mrp5-like protein |
| 09/19/2002 | WO2002072823A2 Human g protein-coupled receptor |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072816A1 Novel mouse type kiss-1 receptor protein and dna thereof |
| 09/19/2002 | WO2002072811A2 Human prenylcysteine lyase-like protein |
| 09/19/2002 | WO2002072808A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | WO2002072805A2 Thymidylate synthase |
| 09/19/2002 | WO2002072799A1 Cd4+cd25+ regulatory t cells from human blood |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072776A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | WO2002072773A2 Methods and compositions for amplification of rna sequences |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072768A2 ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME |
| 09/19/2002 | WO2002072759A2 Method to screen peptide display libraries using minicell display |
| 09/19/2002 | WO2002072752A2 Forms of prostate specific antigens and methods for their detection |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072633A1 Novel overexpressed protein in prostate cancer |
| 09/19/2002 | WO2002072632A2 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 09/19/2002 | WO2002072631A2 Mhc molecule constructs and their usesfor diagnosis and therapy |
| 09/19/2002 | WO2002072630A2 Nucleic acid-associated proteins |
| 09/19/2002 | WO2002072627A2 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination |
| 09/19/2002 | WO2002072626A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
| 09/19/2002 | WO2002072624A2 Assays, methods and means for targeting streptococcal inhibitor of complement (sic) |
| 09/19/2002 | WO2002072622A2 Vaccine antigens against infection by chlamydia trachomatis |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072606A2 Epitope testing using hla |
| 09/19/2002 | WO2002072600A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | WO2002072596A1 Steap-related protein |
| 09/19/2002 | WO2002072588A2 Photo-induced electron transfer fluorescent sensor molecules |
| 09/19/2002 | WO2002072541A2 Human grk7: new member of the human g-protein-coupled-receptor kinase family |
| 09/19/2002 | WO2002072264A1 Method and system for microfluidic interfacing to arrays |
| 09/19/2002 | WO2002072202A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 09/19/2002 | WO2002072140A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072126A2 Invention relating to hcv diseases |
| 09/19/2002 | WO2002072088A2 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 09/19/2002 | WO2002072030A2 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | WO2002072013A2 Method of treating malignancies through induction of blood immune responses |
| 09/19/2002 | WO2002071929A2 Methods of decreasing non-specific binding in dual bead assays and system apparatus for detecting medical targets |
| 09/19/2002 | WO2002071928A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 09/19/2002 | WO2002071851A1 Ethylene gas adsorbent, method of controlling ethylene gas concentration and ethylene gas sensor |
| 09/19/2002 | WO2002071832A1 Method of assessing standing trees |
| 09/19/2002 | WO2002060575A3 Well-based biosensor for detecting molecular or cellular events |
| 09/19/2002 | WO2002059372A3 Three dimensional biochip |
| 09/19/2002 | WO2002057481A3 Repeat-free probes for molecular cytogenetics |
| 09/19/2002 | WO2002056026B1 Novel proteome analysis method and devices therefor |
| 09/19/2002 | WO2002055663A3 Srebp pathway modulation through targeting hisrs |
| 09/19/2002 | WO2002055654A3 Immunosubtraction method for sample preparation for 2-dge |
| 09/19/2002 | WO2002052260A9 Biosensor and method of producing the same |
| 09/19/2002 | WO2002050119A3 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 09/19/2002 | WO2002048391A3 Dormancy - induced mycobacterium proteins |
| 09/19/2002 | WO2002046721A3 Optical discs for measuring analytes |
| 09/19/2002 | WO2002044713A3 Flow through device for two dimensional incubation and/or hybridization on solid supports |
| 09/19/2002 | WO2002042311A3 Biotin derivatives, methods for making same and uses thereof as vectors |
| 09/19/2002 | WO2002033119A9 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2002 | WO2002033079A3 Human g-protein coupled receptor and uses thereof |
| 09/19/2002 | WO2002025316A3 Acoustically monitoring concrete vessels and structures |
| 09/19/2002 | WO2002022871A3 Polymorphic bone morphogenetic protein 2 |
| 09/19/2002 | WO2002022853A9 Method for measuring the activity of the blood clotting factor xiiia |
| 09/19/2002 | WO2002020841A3 5-hydroxytryptamine receptor gene polymorphisms and response to treatment |
| 09/19/2002 | WO2002019407A3 A method for spatial distribution of chemical groups on a semiconductor surface |
| 09/19/2002 | WO2002018553A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/19/2002 | WO2002017949A9 Novel functions for dp214 |
| 09/19/2002 | WO2002014355A3 Novel mitogen activated kinase |
| 09/19/2002 | WO2002012887A3 Methods and compositions for the diagnosis and treatment of brown adipose cell disorders |
| 09/19/2002 | WO2002010382A9 Trp8, trp9 and trp10, markers for cancer |
| 09/19/2002 | WO2002006825A9 Biochemical markers of the human endometrium |
| 09/19/2002 | WO2002006517A3 High-throughput methods for generating and screening compounds that affect cell viability |
| 09/19/2002 | WO2002004953A3 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 09/19/2002 | WO2002004656A3 Bio-probes and use thereof |
| 09/19/2002 | WO2002003072A8 A method for extracting quantitative information relating to interactions between cellular components |
| 09/19/2002 | WO2002002810A3 Method for qualitative and/or quantitative detecting of molecular interactions on probe arrays |
| 09/19/2002 | WO2002002610A3 Secretion and trafficking molecules |
| 09/19/2002 | WO2001098785A3 Rapid flow-based immunoassay microchip |
| 09/19/2002 | WO2001090188A9 Receptor-based interaction trap |
| 09/19/2002 | WO2001088162A3 Methods and vectors for generating antibodies in avian species and uses therefor |
| 09/19/2002 | WO2001086263A3 Apparatus and methods for detecting explosives and other substances |
| 09/19/2002 | WO2001085956A3 Lipid metabolism enzymes |
| 09/19/2002 | WO2001085769A3 Structure of g-protein (rgs4) and methods of identifying agonists and antagonists using same |
| 09/19/2002 | WO2001083514A3 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof |
| 09/19/2002 | WO2001070386A2 Polyfunctional support material for complex nucleic acid analysis |
| 09/19/2002 | WO2001066740A3 Compositions and methods for the treatment of immune related diseases |
| 09/19/2002 | WO2001064949A3 Diagnostics and therapeutics for glaucoma |
| 09/19/2002 | WO2001057520A3 Analytical measuring and evaluation method for molecular interactions |
| 09/19/2002 | WO2001024328A9 Method of converting an optical wavelength with an opto-electronic laser with integrated modulator |